Go Pro

Alamar Biosciences (ALMR) Earnings Date, Estimates & Call Transcripts

$33.16 +0.24 (+0.73%)
As of 08/14/2026 04:00 PM Eastern

Alamar Biosciences Earnings Summary

Alamar Biosciences issued Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.22, which beat the consensus estimate of -$0.36 by $0.14. Quarterly revenue was reported to be $29.43 million. With a trailing EPS of -$1.74, Alamar Biosciences' earnings are expected to grow next year, from ($1.23) to ($0.67) per share.

Consensus EPS
(Aug. 11)
-$0.36
Actual EPS
(Aug. 11)
-$0.22 Beat By $0.14
Actual Revenue
(Aug. 11)
$29.43M

Q2 2026 Earnings Resources

Get Alamar Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alamar Biosciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ALMR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALMR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Alamar Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.23) EPS
Next Year EPS Consensus Estimate
($0.67) EPS

Alamar Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026-$0.36-$0.22+$0.14-$0.22-$29.43M
5/8/2026Q1 2026--$1.74--$1.74-$26.04M

Alamar Biosciences Earnings - Frequently Asked Questions

Alamar Biosciences (NASDAQ:ALMR) last announced its quarterly earning data on Tuesday, August 11, 2026. Learn more on ALMR's earnings history.

Alamar Biosciences updated its FY 2026 earnings guidance on Monday, August, 10th. The company issued revenue guidance of $116.0 million-$120.0 million, compared to the consensus revenue estimate of $113.1 million.

In the previous quarter, Alamar Biosciences (NASDAQ:ALMR) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.36) by $0.14. Learn more on analysts' earnings estimate vs. ALMR's actual earnings.

The conference call for Alamar Biosciences' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Alamar Biosciences' latest earnings report can be read online.
Read Transcript

Alamar Biosciences (NASDAQ:ALMR) has a recorded annual revenue of $74.21 million.

Alamar Biosciences (NASDAQ:ALMR) has a recorded net income of -$29.82 million. ALMR has generated -$1.74 earnings per share over the last four quarters.

Alamar Biosciences' earnings are expected to grow from ($1.23) per share to ($0.67) per share in the next year.


Earnings data for NASDAQ:ALMR is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings.
From Our Partners